Q4 2024 · 13F-HR
SILVERARC CAPITAL MANAGEMENT, LLCholdings as filed
Filed 2025-02-14 · accession 0001420506-25-000497
$457.2M
Reported value
61
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 670703107 | NUVL | NUVALENT INC | $31.3M | 6.85% | 400,014 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $28.6M | 6.26% | 680,845 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $25.7M | 5.62% | 372,230 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $24.0M | 5.24% | 516,014 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $20.6M | 4.50% | 739,563 | Common | SOLE |
| 92337F107 | VCYT | VERACYTE INC | $19.9M | 4.36% | 503,281 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $18.9M | 4.14% | 7,543,901 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $17.3M | 3.79% | 1,315,601 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $16.3M | 3.56% | 1,230,400 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $15.8M | 3.46% | 543,651 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $15.3M | 3.35% | 273,896 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $15.0M | 3.27% | 179,085 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $11.9M | 2.61% | 1,120,473 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $10.0M | 2.19% | 598,952 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $9.9M | 2.18% | 1,000,000 | Common | SOLE |
| 73730P108 | PSTXUSD | POSEIDA THERAPEUTICS INC | $9.7M | 2.13% | 1,012,307 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $9.5M | 2.08% | 1,178,300 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $9.3M | 2.03% | 3,065,649 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $7.9M | 1.73% | 183,243 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $7.5M | 1.65% | 608,897 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $7.2M | 1.57% | 921,137 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $7.1M | 1.55% | 51,491 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $7.0M | 1.53% | 110,381 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $6.7M | 1.46% | 264,560 | Common | SOLE |
| 05479K106 | ELUT | ELUTIA INC | $6.7M | 1.46% | 1,782,271 | Common | SOLE |
| 09075X108 | — | BIODESIX INC | $6.6M | 1.45% | 4,332,281 | Common | SOLE |
| 00973Y908 | — | AKERO THERAPEUTICS INC | $6.1M | 1.34% | 220,000 | CALL | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $5.6M | 1.22% | 6,171,847 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $5.6M | 1.22% | 72,516 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $5.4M | 1.18% | 513,369 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $5.2M | 1.14% | 124,388 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $5.2M | 1.13% | 612,173 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $4.8M | 1.06% | 277,365 | Common | SOLE |
| 12529R107 | CCCC | C4 THERAPEUTICS INC | $4.4M | 0.96% | 1,221,131 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $4.1M | 0.90% | 152,395 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $3.7M | 0.80% | 65,955 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $3.4M | 0.74% | 49,000 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $3.3M | 0.73% | 40,788 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $3.3M | 0.71% | 920,022 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $3.0M | 0.66% | 734,234 | Common | SOLE |
| M25722105 | CGEN | COMPUGEN LTD | $2.5M | 0.54% | 1,624,377 | Common | SOLE |
| 157085101 | CERS | CERUS CORP | $2.4M | 0.53% | 1,587,228 | Common | SOLE |
| 87164F905 | — | SYNDAX PHARMACEUTICALS INC | $2.3M | 0.50% | 172,400 | CALL | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $2.1M | 0.46% | 285,120 | Common | SOLE |
| 90466Y103 | — | UNICYCIVE THERAPEUTICS INC | $2.0M | 0.43% | 2,486,709 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $1.9M | 0.42% | 100,000 | Common | SOLE |
| 24661P807 | DCTH | DELCATH SYS INC | $1.9M | 0.41% | 155,325 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $1.8M | 0.39% | 100,000 | Common | SOLE |
| 60785L207 | — | MODULAR MED INC | $1.7M | 0.38% | 1,272,015 | Common | SOLE |
| 483119202 | KALAEUR | KALA BIO INC | $1.6M | 0.35% | 231,070 | Common | SOLE |
| 640979900 | — | NEUMORA THERAPEUTICS INC. | $1.6M | 0.34% | 147,200 | CALL | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $1.4M | 0.30% | 233,281 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $923,700 | 0.20% | 10,000 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $903,491 | 0.20% | 121,274 | Common | SOLE |
| 75041J101 | RADX | RADIOPHARM THERANOSTICS LTD | $841,453 | 0.18% | 187,406 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $754,716 | 0.17% | 96,511 | Common | SOLE |
| 92243A200 | VXRT | VAXART INC | $713,599 | 0.16% | 1,077,782 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $403,068 | 0.09% | 595,990 | Common | SOLE |
| 35168W103 | GUTS | FRACTYL HEALTH INC | $364,459 | 0.08% | 176,922 | Common | SOLE |
| 09077V100 | BIOA | BIOAGE LABS INC | $231,449 | 0.05% | 39,974 | Common | SOLE |
| 77313F114 | RCKTW | ROCKET PHARMACEUTICALS INC | $3,596 | 0.00% | 104,828 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.